311 Shares in Laboratory Corp. of America Holdings (LH) Purchased by Quantamental Technologies LLC

Quantamental Technologies LLC purchased a new position in Laboratory Corp. of America Holdings (NYSE:LH) in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 311 shares of the medical research company’s stock, valued at approximately $39,000.

Several other large investors also recently modified their holdings of the company. Northwest Investment Counselors LLC lifted its stake in Laboratory Corp. of America by 1.4% during the fourth quarter. Northwest Investment Counselors LLC now owns 17,139 shares of the medical research company’s stock valued at $2,166,000 after purchasing an additional 240 shares during the last quarter. Cubic Asset Management LLC lifted its stake in Laboratory Corp. of America by 10.9% during the fourth quarter. Cubic Asset Management LLC now owns 5,456 shares of the medical research company’s stock valued at $689,000 after purchasing an additional 536 shares during the last quarter. JFS Wealth Advisors LLC acquired a new stake in Laboratory Corp. of America during the fourth quarter valued at approximately $26,000. Inlet Private Wealth LLC acquired a new stake in Laboratory Corp. of America during the fourth quarter valued at approximately $1,630,000. Finally, Supplemental Annuity Collective Trust of NJ acquired a new stake in Laboratory Corp. of America during the fourth quarter valued at approximately $632,000. 91.97% of the stock is owned by institutional investors.

Several analysts recently commented on the stock. Zacks Investment Research raised shares of Laboratory Corp. of America from a “sell” rating to a “hold” rating in a research note on Monday. Craig Hallum downgraded shares of Laboratory Corp. of America from a “buy” rating to a “hold” rating in a research report on Monday, December 3rd. Canaccord Genuity downgraded shares of Laboratory Corp. of America from a “buy” rating to a “hold” rating and reduced their price target for the company from $190.00 to $162.00 in a research report on Thursday, October 25th. William Blair restated a “buy” rating on shares of Laboratory Corp. of America in a research report on Monday, December 3rd. Finally, Robert W. Baird reduced their price target on shares of Laboratory Corp. of America from $205.00 to $190.00 and set an “outperform” rating for the company in a research report on Thursday, October 25th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and nine have given a buy rating to the stock. Laboratory Corp. of America presently has a consensus rating of “Hold” and an average target price of $178.27.

Shares of NYSE:LH opened at $146.59 on Wednesday. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.51 and a quick ratio of 1.38. The company has a market capitalization of $14.56 billion, a P/E ratio of 13.30, a PEG ratio of 1.64 and a beta of 1.13. Laboratory Corp. of America Holdings has a 52 week low of $119.38 and a 52 week high of $190.35.

Laboratory Corp. of America (NYSE:LH) last issued its quarterly earnings results on Thursday, February 7th. The medical research company reported $2.52 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.48 by $0.04. The business had revenue of $2.79 billion during the quarter, compared to the consensus estimate of $2.78 billion. Laboratory Corp. of America had a net margin of 8.43% and a return on equity of 17.05%. The firm’s quarterly revenue was up 1.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.45 EPS. On average, research analysts expect that Laboratory Corp. of America Holdings will post 11.21 earnings per share for the current year.

In other Laboratory Corp. of America news, Director R Sanders Williams sold 350 shares of the company’s stock in a transaction that occurred on Tuesday, November 27th. The shares were sold at an average price of $162.14, for a total value of $56,749.00. Following the transaction, the director now owns 7,886 shares in the company, valued at approximately $1,278,636.04. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.73% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY NOTICE: “311 Shares in Laboratory Corp. of America Holdings (LH) Purchased by Quantamental Technologies LLC” was published by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another website, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this article can be accessed at https://www.com-unik.info/2019/02/13/311-shares-in-laboratory-corp-of-america-holdings-lh-purchased-by-quantamental-technologies-llc.html.

Laboratory Corp. of America Profile

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates through two segments, LabCorp Diagnostics and Covance Drug Development. It offers a range of clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, prostate-specific antigen, tests for sexually-transmitted diseases, hepatitis C tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens.

Recommended Story: Why is Cost of Capital Important?

Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Corp. of America Holdings (NYSE:LH).

Institutional Ownership by Quarter for Laboratory Corp. of America (NYSE:LH)

Receive News & Ratings for Laboratory Corp. of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Corp. of America and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit